Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Taxane anticancer agents: a patent perspective.
Ojima I, Lichtenthal B, Lee S, Wang C, Wang X. Ojima I, et al. Expert Opin Ther Pat. 2016;26(1):1-20. doi: 10.1517/13543776.2016.1111872. Epub 2015 Dec 10. Expert Opin Ther Pat. 2016. PMID: 26651178 Free PMC article. Review.
Overcoming multidrug resistance in taxane chemotherapy.
Geney R, Ungureanu lM, Li D, Ojima I. Geney R, et al. Among authors: ojima i. Clin Chem Lab Med. 2002 Sep;40(9):918-25. doi: 10.1515/CCLM.2002.161. Clin Chem Lab Med. 2002. PMID: 12435109 Review.
BMS-184476 Bristol-Myers Squibb.
Ojima I, Geney R. Ojima I, et al. Curr Opin Investig Drugs. 2003 Jun;4(6):732-6. Curr Opin Investig Drugs. 2003. PMID: 12901233 Review.
Antibody-cytotoxic agent conjugates for cancer therapy.
Chen J, Jaracz S, Zhao X, Chen S, Ojima I. Chen J, et al. Among authors: ojima i. Expert Opin Drug Deliv. 2005 Sep;2(5):873-90. doi: 10.1517/17425247.2.5.873. Expert Opin Drug Deliv. 2005. PMID: 16296784 Review.
Therapeutic potential of FtsZ inhibition: a patent perspective.
Awasthi D, Kumar K, Ojima I. Awasthi D, et al. Among authors: ojima i. Expert Opin Ther Pat. 2011 May;21(5):657-79. doi: 10.1517/13543776.2011.568483. Epub 2011 Mar 18. Expert Opin Ther Pat. 2011. PMID: 21413908 Review.
223 results